Bevacizumab/PD-1 inhibitor plus chemotherapy as first-line treatment of advanced non-squamous non-small-cell lung cancer

Wang, J; Chen, Q; Wang, XY; Huang, DZ; Jiang, RC

Jiang, RC (通讯作者)，Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjin, Peoples R China.;Jiang, RC (通讯作者)，Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China.;Jiang, RC (通讯作者)，Tianjin Med Univ, Tianjin Canc Inst & Hosp, Tianjin Lung Canc Ctr, Dept Thorac Oncol, Tianjin 300060, Peoples R China.

JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2023; 12 (5):

Abstract

Aim: To compare the effectiveness of PD-1 inhibitor or bevacizumab plus chemotherapy in advanced nonsquamous non-small cell lung cancer (nsNSCLC).Meth......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索